inPROBE

inPROBE inPROBE. Smart Cancer Diagnostics

inPROBE is a disruptive platform technology which links targeted therapies with targeted diagnostics and has a potential to become a breakthrough in both cancer treatment as well as cancer diagnostics.

Adres

Lublin

Strona Internetowa

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy inPROBE umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Praktyka

Wyślij wiadomość do inPROBE:

Skróty

Udostępnij

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Kategoria

inPROBE - disruptive platform technology in real-time invivo biology diagnosis

Our vision is to help increase cancer survival by 30% by 2030 and co-create the future of fighting cancer with implementing real-time, in vivo and numerical based personalized diagnostics & monitoring inPROBE platform technology.

inPROBE is a disruptive platform technology which links targeted therapies with targeted diagnostics and has a potential to become a breakthrough in both cancer treatment as well as cancer diagnostics. inPROBE is a personalized targeted Point-of-Care technology which can reduce diagnosis time, increase precision and effects of innovative cancer treatments.

inPROBE is merging fiber optics, biotech and bioengineering in a single needle. In essence inPROBE puts the biology diagnostics tests at the tip of the fiber optic microprobe with single-cell resolution giving in vivo (no tissue biopsy) real-time numerical results of cancer biomarkers without the need of tumor infraction. No more false histopathology results, much less pain and waiting time for Patients and numerous scale-up possibilities.

HER2 overexpressed Breast Cancers as first in-human application has been developed and heading towards in-human clinical validation in the coming months, with the support of EU funding (SME Instrument Horizon2020 grant)